PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Nov 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-11-07

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-07	Common Stock	M	3333	$5.95	Acquired	36236624	Direct
2023-11-07	Common Stock	M	9932	$5.95	Acquired	36246556	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-07	Stock Option (right to buy)	$5.95	M	3333	Disposed	2033-05-25	Common Stock (3333)	Direct
2023-11-07	Stock Option (right to buy)	$5.95	M	9932	Disposed	2033-05-25	Common Stock (9932)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	492069	Indirect

Footnotes

F1: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.

F2: Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting.

F3: Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a quarterly basis following the Company's last Annual Stockholder Meeting.